Q93009 (UBP7_HUMAN) Homo sapiens (Human)

Ubiquitin carboxyl-terminal hydrolase 7 UniProtKBInterProSTRINGInteractive Modelling

1102 aa; Sequence (Fasta) ; (Isoform 3)

Available Structures

58 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
USP7CD-UBL45 in complex with Ubiquitin Heteromer
P0CG47;
209-1102
Assess
USP7CD-CTP in complex with Ubiquitin Heteromer
P0CG47;
CA;209-1102
Assess
Crystal structure of USP7/HAUSP in complex with ICP0 Heteromer
P08393;
560-1083
Assess
Crystal structure of DNMT1 in complex with USP7 Heteromer
P26358;
560-1083
Assess
Crystal Structure of human DNMT1 and USP7/HAUSP complex Heteromer
P26358;
ZN;560-1083
Assess
Crystal structure of USP7 in complex with DNMT1(K1115Q) Heteromer
P26358;
GOL;560-1083
Assess
Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquiti… Heteromer
P0CG48;
208-554
Assess
Crystal structure of USP7 ubiquitin-like domains in compact conformation Heteromer
P08393;
CL;540-885
Assess
Crystal structure of USP7 catalytic domain [H294E] mutant in complex with ubiquitin Heteromer
P0CG47;
EPE;209-553
Assess
Crystal structure of USP7 catalytic domain [L299A] mutant in complex with ubiquitin Heteromer
P0CG47;
GOL;208-551
Assess
Crystal structure of USP7 catalytic domain [V302K] mutant in complex with ubiquitin Heteromer
P0CG47;
210-550
Assess
Crystal Structure of Ubl123 with an EZH2 peptide Heteromer
Q15910;
543-883
Assess
Crystal structure of USP7 ubiquitin-like domains in extended conformation Heteromer
P08393;
CL;543-883
Assess
Crystal structure of USP7 catalytic domain [V302K] mutant in complex with ubiquitin (malonate bound) Heteromer
P0CG47;
MLA;GOL;210-549
Assess
Crystal structure of USP7 with RNF169 peptide Heteromer
Q8NCN4;
562-885
Assess
Crystal structure of USP7 in complex with UHRF1 Heteromer
Q96T88;
561-881
Assess
Structure of USP7 with a novel viral protein Heteromer
F5HF68;
GOL;63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 364-367 Heteromer
P04637;
63-205
Assess
Structure of the vIRF4-HAUSP TRAF domain complex Heteromer
Q2HR73;
63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with an EBNA1 peptide Heteromer
P03211;
21×NA;63-205
Assess
Crystal Structure Of USP7-NTD with MCM-BP Heteromer
Q9BTE3;
63-205
Assess
Crystal Structure of the USP7:HdmX(AHSS) complex Heteromer
O15151;
63-205
Assess
Crystal structure of usp7-ntd with an e2 enzyme Heteromer
P51965;
63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with mdm2 peptide 147-150 Heteromer
Q00987;
63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 359-362 Heteromer
P04637;
63-205
Assess
Crystal Structure of the USP7:Hdm2(PSTS) complex Heteromer
Q00987;
63-205
Assess
Crystal structure of USP7 in complex with a 4-hydroxypiperidine based inhibitorhomo-2-merSO4;GOL;CQ5;207-560
Assess
Structure of DUB complexhomo-2-mer9QA;208-554
Assess
Structure of DUB complexhomo-2-mer9QD;ACT;GOL;208-554
Assess
USP7 in complex with a novel inhibitorhomo-2-merEZF;209-553
Assess
structure of usp7 catalytic domain and three ubl-domainsmonomer210-881
Assess
Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activationmonomer211-881
Assess
Mechanism of USP7 (HAUSP) activation by its C-terminal ubiquitin-like domain (HUBL) and allosteric …monomerCL;560-1083
Assess
Crystal structure of HAUSPmonomer64-551
Assess
Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibit…monomerSO4;GOL;8QQ;207-560
Assess
Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibit…monomerSO4;GOL;8RN;207-560
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 1monomerR4D;207-555
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 14monomerR4J;ZN;207-555
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 18monomerR44;ACT;207-554
Assess
Crystal structure of the USP7/HAUSP catalytic domainmonomerBR;208-554
Assess
The Crystal Structure of human USP7 USP domain from Wuxi Biortus.monomerGOL;208-554
Assess
Structure of the catalytic domain of USP7 (HAUSP)monomer208-554
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 7monomerR41;207-553
Assess
Crystal structure of the USP7/HAUSP catalytic domainmonomerBR;209-554
Assess
USP7 in complex with GNE6776 (6'-amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-c…monomer8JP;209-554
Assess
Crystal structure of USP7 in complex with the covalent inhibitor, FT827monomer8WN;EDO;209-554
Assess
USP7 in complex with Cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl)phenol)monomerAJJ;GOL;209-554
Assess
Crystal structure of USP7 in complex with the non-covalent inhibitor, FT671monomer8WK;212-556
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 23monomerR3Y;208-552
Assess
Structure of DUB complexmonomer9HS;ZN;208-552
Assess
USP7 in complex with GNE6640 (4-(2-amino-4-ethyl-5-(1H-indazol-5-yl)pyridin-3-yl)phenol)monomer8JM;210-553
Assess
Crystal structure of the apo-form of USP7 catalytic domain [V302K] mutantmonomerGOL;211-553
Assess
Crystal structure of the first two Ubl domains of Deubiquitylase USP7monomer537-793
Assess
Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a p53 peptidemonomer63-208
Assess
Crystal structure of the TRAF-like domain of HAUSP/USP7monomerCA;63-206
Assess
Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a MDM2 peptidemonomer63-205
Assess
Crystal structure of the N-terminal domain of USP7/HAUSP.monomer65-203
Assess
Solution NMR structure of human ubiquitin specific protease Usp7 UBL domain (residues 537-664). NES…monomer537-664
Assess

4 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.835fwi.1.A210-881
100.00
Assess
monomer0.824yoc.1.B560-1083
100.00
Assess
monomer0.732f1x.1.A63-208
96.18
Assess
monomer0.585jtv.4.A209-1102
98.79
Assess

4 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 3monomer0.835fwi.1.A194-865
100.00
Assess
Isoform 3monomer0.824yoc.1.B544-1067
100.00
Assess
Isoform 3monomer0.742f1x.1.A47-192
96.18
Assess
Isoform 3monomer0.585jtv.4.A193-1086
98.79
Assess

Alignments